Stay updated on TAK-659 in AML Clinical Trial

Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-659 in AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Core content updated with a government operating status notice and a new version tag; a specific disease resource entry was removed.
    Difference
    2%
    Check dated 2025-10-06T04:23:50.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.0%
    Check dated 2025-09-28T23:42:50.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T09:59:50.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T07:56:36.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The web page has added significant information regarding a facility and its location, as well as new publications related to acute myeloid leukemia and the drug TAK-659, while removing references to certain diseases and location details.
    Difference
    3%
    Check dated 2025-08-31T01:05:08.000Z thumbnail image
  9. Check
    70 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.4%
    Check dated 2025-08-23T21:57:18.000Z thumbnail image

Stay in the know with updates to TAK-659 in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.